Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow (FCF).

## AGN Free Cash Flow Analysis

Free cash flow, a measure commonly used by analysts to assess a company's profitability, represents the cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

The Free Cash Flow is calculated using a number of methods including using Operating Cash Flow. Following is the formula to calculate Free Cash Flow based on Operating Cash Flow.

`Free Cash Flow = Operating Cash Flow - Capital Expenditures`

Using above formula to calculate Free Cash Flow for Argenica Therapeutics Limited (AGN), the free cash flow value is -3.36M.

All amounts in AUD

Operating Cash
-3.36M
Capital Expenditure
-
Free Cash Flow
-3.36M

Argenica Therapeutics Limited has a negative free cash flow as per the latest annual Cash flow statement released by the company. Positive free cash flow is cruscial for the financial health of a company, which can be used to pay dividends, expand operations, and deleverage its balance sheet (i.e., reduce debt).

## AGN Cash Flow Statement History

Following table shows the history of Cash Flow Statements sheet for Argenica Therapeutics Limited (ASX:AGN).

30 Jun 2022 30 Jun 2021 30 Jun 2020
Net Income -4.09M -1.03M -657.26k
Change To Netincome 425.34k 268.22k 268.22k
Change To Account Receivables -671 -92.6k -59.45k
Change To Liabilities 286.7k -199.72k 615.88k
Change To Operating Activities 17.71k 7.19k 7.19k
Total Cash From Operating Activities -3.36M -1.05M -100.83k
Total Cash From Financing Activities 5.13M 7.85M 687.09k
Change In Cash 1.77M 6.8M 586.26k
Issuance Of Stock 5.13M 7.85M 687.09k